Pathkey.AI Ltd (ASX:PKY)
0.0350
-0.0030 (-7.89%)
Sep 9, 2026, 4:10 PM AEST
Pathkey.AI Company Description
Pathkey.AI Ltd, a technology company, develops agentic AI solutions in Australia.
The company offers Chipforge, an AI-native semiconductor design and verification platform. It also provides Trialkey, an AI platform for clinical-trial design and prediction.
The company was formerly known as Opyl Limited and changed its name to Pathkey.AI Ltd in August 2025.
Pathkey.AI Ltd was incorporated in 1994 and is based in Sydney, Australia.
Pathkey.AI Ltd
| Country | Australia |
| Founded | 1994 |
| Industry | Health Information Services |
| Sector | Healthcare |
| CEO | Andrew Farnsworth |
Contact Details
Address: Level 12 Sydney, NSW 2000 Australia | |
| Phone | 61 3 9923 1222 |
| Website | pathkey.ai |
Stock Details
| Ticker Symbol | PKY |
| Exchange | Australian Securities Exchange |
| Fiscal Year | July - June |
| Reporting Currency | AUD |
| ISIN Number | AU0000415291 |
| SIC Code | 1000 |
Key Executives
| Name | Position |
|---|---|
| Andrew Farnsworth | Chief Executive Officer |
| Mark Ziirsen | Chief Financial Officer |
| Bernice Averion | Head of Marketing and Communications |
| Shane Lewis | Vice President of Sales and Partnerships |
| Matt Hallam | Chief Revenue Officer |
| Jonathan Hart B.Com., L.L.B. | Company Secretary |